Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7125-7133
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7125
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7125
Response | Definition |
Complete response | Disappearance of all lesions; No new lesions |
Partial response | A decrease in size1 of ≥ 10% or decrease in tumor density (HU) ≥ 15% on CT; No new lesions; No obvious progression of nonmeasurable disease |
Stable disease | Dose not meet criteria for complete response, partial response, or progressive disease; No symptomatic deterioration attributed to tumor progression |
Progressive disease | An increase in tumor size of ≥ 10% and does not meet criteria of partial response by tumor density (HU) on CT; New lesions; New intratumoral nodules or increase in size of existing intratumoral nodules |
- Citation: Wang MX, Devine C, Segaran N, Ganeshan D. Current update on molecular cytogenetics, diagnosis and management of gastrointestinal stromal tumors. World J Gastroenterol 2021; 27(41): 7125-7133
- URL: https://www.wjgnet.com/1007-9327/full/v27/i41/7125.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i41.7125